Ayelet Levy

Ayelet Levy has been in the workforce since 2000, beginning their career in the Technology Intelligence Unit of the Israeli Defense Forces' Intelligence Corps. In 2006, they worked as an Anti Fraud Analyst at RSA The Security Division of EMC. From 2007 to 2013, Levy was a Ph.D. Student in the Interdisciplinary Doctoral Program in Neurosciences for outstanding students at Tel Aviv University. While there, they initiated and established experimental systems, designed, conducted, and analyzed research aimed at establishing CD38 targeting as a novel therapeutic approach for brain pathologies, including cancer and neurodegenerative diseases. Ayelet also led and supervised a research team of one Ph.D. and two undergraduate students. From 2013 to 2016, Levy was a Postdoctoral Research Fellow at Inserm, studying novel modes of inter-cellular communication in skin biology and repair, and their role in aging and pathology. In Prof. Daniel Aberdam's lab at Hôpital Saint-Louis. Finally, from 2016 to 2020, Levy was a Modeling and Analytics Lead at Signals Analytics, and then a Senior Data Analyst and Data Team Lead at CLEW.

Ayelet Levy completed their education history with a Doctor of Philosophy - PhD in Neuroscience from Tel Aviv University in 2012. Ayelet had previously earned a Bachelor of Science (BSc) in Neuroscience from Tel Aviv University in 2007.